Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on BIA 6-512 (Trans-resveratrol) PK
NCT03095092Phase 1Completed
- Sponsor
- BIAL
- Start
- May 2005
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of resveratrol in Parkinson's disease (PD), sponsored by BIAL. Primary endpoint: Maximum plasma concentration at 24 hours. Started May 2005; status: completed.
02
Drugs
resveratrol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03095092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03095092.